Israel - Hebrew - Ministry of Health

teva pharmaceutical industries ltd, israel - cilazapril - טבליה - cilazapril 5 mg - cilazapril - cilazapril - treatment of essential hypertension, renal hypertension and chronic heart failure.

Israel - Hebrew - Ministry of Health

teva pharmaceutical industries ltd, israel - cilazapril - טבליה - cilazapril 5 mg - cilazapril - cilazapril - treatment of essential hypertension, renal hypertension and chronic heart failure.

Israel - Hebrew - Ministry of Health

teva pharmaceutical industries ltd, israel - cilazapril as monohydrate; hydrochlorothiazide - טבליה - cilazapril as monohydrate 5 mg; hydrochlorothiazide 12.5 mg - cilazapril - cilazapril - treatment of essential hypertension in patients who have been stabilized on the individual components given in the same proportions.

Israel - Hebrew - Ministry of Health

teva pharmaceutical industries ltd, israel - hydrochlorothiazide; ramipril - טבליה - ramipril 2.5 mg; hydrochlorothiazide 12.5 mg - ramipril and diuretics - ramipril and diuretics - essential hypertension. ramipril plus is indicated in patients whose blood pressure cannot be adequately lowered with ramipril alone.

Israel - Hebrew - Ministry of Health

teva pharmaceutical industries ltd, israel - hydrochlorothiazide; ramipril - טבליה - ramipril 2.5 mg; hydrochlorothiazide 12.5 mg - ramipril and diuretics - ramipril and diuretics - essential hypertension. ramipril plus is indicated in patients whose blood pressure cannot be adequately lowered with ramipril alone.

Israel - Hebrew - Ministry of Health

teva pharmaceutical industries ltd, israel - hydrochlorothiazide; ramipril - טבליה - ramipril 5 mg; hydrochlorothiazide 25 mg - ramipril and diuretics - ramipril and diuretics - essential hypertension. ramipril plus is indicated in patients whose blood pressure cannot be adequately lowered with ramipril alone.

Israel - Hebrew - Ministry of Health

teva pharmaceutical industries ltd, israel - hydrochlorothiazide; ramipril - טבליה - ramipril 5 mg; hydrochlorothiazide 25 mg - ramipril and diuretics - ramipril and diuretics - essential hypertension. ramipril plus is indicated in patients whose blood pressure cannot be adequately lowered with ramipril alone.

Israel - Hebrew - Ministry of Health

teva pharmaceutical industries ltd, israel - hydrochlorothiazide; losartan potassium - טבליה - hydrochlorothiazide 12.5 mg; losartan potassium 50 mg - losartan and diuretics - losartan and diuretics - losartan plus teva is indicated for the treatment of hypertension, for patients in whom combination therapy is appropriate. to reduce the risk of stroke in patients with hypertension and left ventricular hypertrophy.

Israel - Hebrew - Ministry of Health

teva pharmaceutical indust.ltd - atorvastatin as calcium 10 mg - tablets - atorvastatin - atorvastatin teva is indicated as an adjunct to diet for reduction of elevated total cholesterol ldl- cholesterol apolipoprotein b and triglycerides and to increase hdl cholesterol in patients with primary hypercholesterolaemia including familial hypercholesterolaemia (heterozygous variant) or combined (mixed) hyperlipidaemia (corresponding to types iia and iib of the fredrickson classification) when response to diet and other nonpharmacological measures is inadequate. atorvastatin teva is also indicated to reduce total-c and ldl -c in patients with homozygous familial hypercholesterolemia as an adjunct to other lipid-lowering treatment (e.g. ldl apheresis) or if such treatments are unavailable. pediatric patients (10-17 years of age) : atorvastatin is indicated as an adjunct to diet to reduce total -c ldl-c and apo b levels in boys and postmenarchal girls 10 to 17 years of age with heterozygous familial hypercholesterolemia if after an adequate trial of diet therapy the following findings are present: 1. ldl

Israel - Hebrew - Ministry of Health

teva pharmaceutical industries ltd, israel - atorvastatin as calcium - טבליה - atorvastatin as calcium 10 mg - atorvastatin - atorvastatin - atorvastatin teva is indicated as an adjunct to diet for reduction of elevated total cholesterol ldl- cholesterol apolipoprotein b and triglycerides and to increase hdl cholesterol in patients with primary hypercholesterolaemia including familial hypercholesterolaemia (heterozygous variant) or combined (mixed) hyperlipidaemia (corresponding to types iia and iib of the fredrickson classification) when response to diet and other nonpharmacological measures is inadequate. atorvastatin teva is also indicated to reduce total-c and ldl -c in patients with homozygous familial hypercholesterolemia as an adjunct to other lipid-lowering treatment (e.g. ldl apheresis) or if such treatments are unavailable. pediatric patients (10-17 years of age) : atorvastatin is indicated as an adjunct to diet to reduce total -c ldl-c and apo b levels in boys and postmenarchal girls 10 to 17 years of age with heterozygous familial hypercholesterolemia if after an adequate trial of diet therapy the following findings are present: 1. ldl